Description
Ceftriaxone is a third generation cephalosporin antibiotic, which targets gram-negative and gram-positive bacteria. It has been used in proteomics research and to study prophylactic strategies to treat hemolytic anemia caused by prescription medications. In addition, ceftriaxone has been used to study the penicillin binding proteins, especially PBP1. It has been suggested that it also increases EAA2 pump expression in the central nervous system and decreases glutamatergic toxicity. It is freely soluble in aqueous solution.
Cephalosporins are a type of β-lactam antibiotic consisting of a four-membered β-lactam ring bound to a six-membered dihydrothiazine ring. This two-ring system causes distortion of the β-lactam amide bond, resulting in decreased resonance stabilization and increased reactivity. β-lactams inhibit the formation of peptidoglycan cross-links within bacterial cell walls by targeting penicillin-binding proteins or PBPs. Consequently, the bacterial cell wall becomes weak and cytolysis occurs. Cephalosporins are less susceptible to β-lactamases than the penicillin β-lactam antibiotics.
Product Specifications
Ceftriaxone Sodium, USP Grade
Ceftriaxone Disodium Salt Hemi(heptahydrate), USP Grade
Formula: C18H16N8Na2O7S3 ∙ 3.5 H2O
MW: 661.60 g/mol
Storage/Handling: Store at 4°C.
PubChem CID: 124202479
